KEYNOTE SPEAKERS
| Home | FAQs | Partnership Opportunities | Registration | Schedule | Youth Leadership |
Monday, July 27, 10:30-11:30 am EDT | Opening Plenary | |
 | Elinore F. McCance-Katz, M.D., Ph.D., Assistant Secretary for Mental Health and Substance Use, SAMHSA, will participate as this year’s Mid-Year Keynote Speaker. Her powerful and informative presentations always leaves a mark on those in the prevention field. Dr. McCance-Katz is the first Assistant Secretary for Mental Health and Substance Use. She obtained her Ph.D. from Yale University with a specialty in Infectious Disease Epidemiology and is a graduate of the University of Connecticut School of Medicine. She is board certified in General Psychiatry and in Addiction Psychiatry. Additionally, Dr. McCance-Katz is a Distinguished Fellow of the American Academy of Addiction Psychiatry with more than 25 years as a clinician, teacher and clinical researcher. Read her full biography. |
Tuesday, July 28, 1-1:30 pm EDT | |
 | VADM Jerome M. Adams, M.D., M.P.H., is the 20th Surgeon General of the United States. His mission as the “Nation’s Doctor,” is to advance the health of the American people. Dr. Adams’ motto as Surgeon General is “better health through better partnerships.” He is committed to strengthening relationships with all members of the health community, and forging new partnerships with members from the business, faith, education and public safety and national security communities. |
Tuesday, July 28, 4:30-5 pm EDT | |
 | Debra Houry, M.D., M.P.H., is the Director of the National Center for Injury Prevention and Control (NCIPC) at CDC. In this role, Dr. Houry leads innovative research and science-based programs to prevent injuries and violence and to reduce their consequences. |
Wednesday, July 29, 1-1:30 pm EDT | Why Today’s Marijuana is Actually an Emerging Drug Threat | |
 | Bertha Madras, Ph.D., is a professor of psychobiology at Harvard Medical School, based at McLean Hospital and cross appointed at the Massachusetts General Hospital. Her research focuses on neurobiology, imaging, and medications development (19 U.S. and 27 international patents) for neuropsychiatric disorders. In public policy, she was deputy director for demand reduction in the White House Office of National Drug Control Policy, a presidential appointment confirmed unanimously by the U.S. Senate. |
Wednesday, July 29, 4:30-5 pm EDT | |
 | Nora D. Volkow, M.D., is Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. NIDA supports most of the world’s research on the health aspects of drug use and addiction. Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a disease of the human brain.
|
Thursday, July 30, 4:30-5 pm EDT | |
 | Arthur T. Dean became the Chairman and CEO of Community Anti-Drug Coalitions of America (CADCA) on August 31, 1998. His responsibilities as Chairman and CEO include providing strategic direction, diversifying and increasing funding, leading the board, being the primary spokesman for the organization and overseeing the operations and personnel of CADCA. |
